Georgia Retina Participates in Apellis Pharmaceuticals' Groundbreaking Clinical Trials for SYFOVRE, the first and only FDA-approved treatment for Geographic Atrophy
Practice was amongst the first in the country to participate in the trialsClick here to download a photo of the SYFOVRE productFor further details about the SYFOVRE clinical study research, click here.ATLANTA--(BUSINESS WIRE)--Georgia Retina is proud to be among the first eyecare practices throughout the country to...